“You planning to sell this?”
“Eventually.”
“To who?”
“Don't know.”
Harold laughed.
Not maliciously.
Then.
“Lily, you're grieving.”
She stiffened.
He softened his tone.
“Your father loved experiments.”
“He did.”
“Arthur also planted market tobacco because experiments don't pay mortgages.”
She knew.
Harold continued.
“Use one acre if you need to keep his project alive.”
“I planted four.”
“Four isn't terrible.”
It became terrible at harvest.
The leaf cured badly by conventional standards.
Harold inspected it in the barn.
He turned one piece over.
Then another.
“Can't buy this.”
Lily had expected that.
Still hurt.
“How bad?”
“Very.”
“Any grade?”
“Not one I can justify.”
“Industrial?”
Harold stared.
“What?”
She asked about chemical buyers.
Processors.
Extraction companies.
Harold laughed.
This time more openly.
“You're growing tobacco for a chemistry set?”
Lily's face heated.
“Maybe.”
“Then call a chemist.”
He left.
Word spread.
Arthur Voss's daughter had grown four acres nobody wanted.
Year one.
Failure.
Except Lily kept samples.
She dried them separately.
Labeled them.
Mailed letters.
North Carolina State.
Duke.
University agricultural programs.
Chemical companies.
Twenty-three letters.
Four replies.
Three polite rejections.
One from Dr. Samuel Greene, a plant biochemist at a state research laboratory.
He wrote:
YOUR DESCRIPTION IS INTERESTING, BUT WE WOULD NEED PROPERLY PREPARED SAMPLES AND CONTROLS BEFORE DRAWING ANY CONCLUSION.
Lily read the sentence ten times.
Not yes.
Not no.
A door.
She prepared samples from V-17 and from a conventional tobacco variety grown in adjacent soil.
Dr. Greene tested them.
Months later, a letter arrived.
The results were inconclusive.
Some V-17 samples showed elevated levels of the compound Arthur had been interested in.
Not enough samples.
Variation too high.
Need replication.
Lily smiled for the first time in weeks.
Everybody else saw failure.
She saw:
Need replication.
In 1981, she planted twelve acres.
Harold called it stubbornness.
Earl called it grief farming.
Marvin called it weeds with paperwork.
Lily grew conventional tobacco on twenty acres to generate income.
Corn and soybeans filled additional ground.
The farm barely survived.
She repaired equipment instead of replacing it.
Worked mornings before sunrise.
Evenings after heat dropped.
Kept Arthur's notes.
Added her own.
V-17 behaved differently depending on nitrogen.
Too much produced huge leaves but lower concentration in test samples.
Moderate stress appeared to increase the waxy surface material.
She experimented carefully.
Not recklessly.
Dr. Greene helped by mail and occasional phone calls.
He never promised a market.
Repeatedly warned her.
“Interesting chemistry does not equal commercial value.”
Lily wrote that sentence on the wall above her desk.
Year two samples were stronger.
More consistent.
Still not enough.
A regional agricultural buyer offered a tiny amount for research.
Barely covered shipping.
Harold heard.
He came by.
“Heard you sold your magic tobacco.”
“Some.”
“For how much?”
“Enough.”
“Enough to pay the mortgage?”
“No.”
“Then it's not farming.”
Lily looked at him.
“What is?”
“Growing something people buy.”
“They bought it.”
Harold laughed.
“You know what I mean.”
She did.
She also knew he was partly right.
That was what made him difficult.
Lily was not battling a fool.
Harold understood agricultural markets.
He understood cash.
He understood that a crop without a reliable buyer was a liability.
His error was not caution.
His error was assuming the current market was the only possible one.
By year three, Lily was exhausted.
Twenty-two.
Hands calloused.
Back sore.
One tractor running badly.
Farm account dangerously low.
The bank sent a notice about restructuring.
She had enough conventional crop income to survive but not enough to repair everything.
V-17 now occupied eighteen acres.
Every neighbor thought that number proved insanity.
Eighteen acres of “worthless” tobacco.
Harold's phrase spread.
Useless tobacco.
People said it at the feed store.
At church.
At auctions.
Sometimes joking.
Sometimes sympathetically.
Lily hated sympathy more.
She also had one thing they did not know.
A new lab report.
Dr. Greene had connected her with a private analytical laboratory working with Harrington Pharmaceutical Materials, a company that supplied purified plant-derived precursors to drug and biochemical manufacturers.
The company had been searching for reliable domestic sources of a compound extracted from tobacco leaves because their existing supply chain depended heavily on overseas material with inconsistent purity.
They were not looking for smoking tobacco.
Color did not matter the same way.
Traditional cure grade barely mattered.
Leaf chemistry mattered.
Consistency mattered.
Traceability mattered.
And V-17, according to preliminary tests, contained nearly twice the target compound concentration of several standard tobacco samples evaluated under similar conditions.
Lily read that result three times.
Then called Dr. Greene.
“Is that good?”
He laughed.
“It's interesting.”
“You always say interesting.”
“Because I am a scientist.”
“What would a farmer say?”
“A farmer would probably say don't spend the money yet.”
Lily smiled.
“That's less interesting.”
“Listen to me.”
His voice became serious.
“One good set of samples is not a business.”
“I know.”
“They need more material.”
“I have it.”
“They need independent confirmation.”
“Okay.”
“They need agronomic stability.”
“I have three years of notes.”
Silence.
“You really do sound like Arthur.”
Lily smiled faintly.
“You knew him?”
“Met him once.”
She froze.
“What?”
Dr. Greene hesitated.
“He wrote me.”
“When?”
“1978.”
Lily sat down.
“You never told me.”
“I didn't realize the connection until I found the old correspondence.”
“What did he say?”
“He believed he'd developed unusually high-solanesol leaf.”
Lily closed her eyes.
Arthur had already reached out.
“Did you test it?”
“No.”
“Why?”
“He never sent samples.”
Arthur died before he could.
Lily looked toward the field through the kitchen window.
For three years she had wondered whether she had transformed grief into obsession.
Now she knew Arthur had been trying to reach the same door.
Dr. Greene continued.
“Harrington wants a larger sample.”
“How much?”
“Fifty pounds cured.”
“I can do that.”
“And full field records.”
“I have them.”
“They may send somebody.”
“Who?”
“Don't know.”
That somebody became Charles Whitmore.
Executive vice president for raw-material sourcing at Harrington Pharmaceutical Materials.
Fifty-one.
Chemist by training.
Corporate by occupation.
According to Dr. Greene, Charles had spent twenty years buying botanical and agricultural feedstocks from suppliers around the world.
He did not care what a crop looked like from the highway.
He cared whether laboratory results repeated.
In April, Lily shipped fifty pounds.
May passed.
Nothing.
June.
Nothing.
July.
Dr. Greene said testing continued.
August came.
The bank sent another letter.
Then Harold arrived at the fence.
Three years.
Useless tobacco.
Your father would've been sick.
That was when Lily saw the black sedan.